Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Disorders”

913 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 913 results

Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00632242
What this trial is testing

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Who this might be right for
Purpura, Thrombotic ThrombocytopenicVon Willebrand Disease Type-2b
Archemix Corp. 28
Not applicableLooking for participantsNCT05378308
What this trial is testing

NOACs Use in AF or VTE (SUNSHINE Registry)

Who this might be right for
Atrial FibrillationVenous ThromboembolismOral Anticoagulant
Henan Provincial People's Hospital 5,000
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Post-approval studies (Phase 4)UnknownNCT04502017
What this trial is testing

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Who this might be right for
Device-Related ThrombosisAtrial FibrillationLeft Atrial Appendage Occlusion
Texas Cardiac Arrhythmia Research Foundation 360
Testing effectiveness (Phase 2)Ended earlyNCT04128956
What this trial is testing

Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS

Who this might be right for
Venous ThrombosesStent Stenosis
University of Zurich 172
Large-scale testing (Phase 3)Study completedNCT00116688
What this trial is testing

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 313
Post-approval studies (Phase 4)Ended earlyNCT04794569
What this trial is testing

Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome

Who this might be right for
Deep Vein ThrombosisPost Thrombotic Syndrome
Sunnybrook Health Sciences Centre 9
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Not applicableUnknownNCT03288441
What this trial is testing

Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia

Who this might be right for
Hematologic NeoplasmsThrombocytopeniaAnticoagulants+1 more
Maastricht University Medical Center 300
Large-scale testing (Phase 3)Study completedNCT00370331
What this trial is testing

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 197
Testing effectiveness (Phase 2)Study completedNCT04056195
What this trial is testing

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Oscotec Inc. 61
Not applicableUnknownNCT02892630
What this trial is testing

Immune Thrombocytopenia in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Assistance Publique - Hôpitaux de Paris 300
Not applicableStudy completedNCT03795883
What this trial is testing

The Thrombotic Potential of Heart Chambers in the Presence or Absence of Atrial Fibrillation.

Who this might be right for
Atrial FibrillationThrombosis CardiacLeft Atrial Thrombosis
Rambam Health Care Campus 47
Not applicableNot Yet RecruitingNCT06466824
What this trial is testing

Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010

Who this might be right for
Primary Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 157
Large-scale testing (Phase 3)Study completedNCT01225562
What this trial is testing

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Who this might be right for
Myocardial InfarctionCardiovascular DeathAtherothrombosis+1 more
AstraZeneca 21,379
Not applicableStudy completedNCT04481997
What this trial is testing

Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

Who this might be right for
Type2 Diabetes MellitusCoronary Heart Disease
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA 1,000
Testing effectiveness (Phase 2)Ended earlyNCT00726544
What this trial is testing

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyThrombotic Thrombocytopenic Purpura
Archemix Corp. 100
Post-approval studies (Phase 4)Study completedNCT02159521
What this trial is testing

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

Who this might be right for
Deep Vein ThrombosisPost-thrombotic Syndrome
Boston Scientific Corporation 81
Large-scale testing (Phase 3)Ended earlyNCT00411801
What this trial is testing

Safety and Efficacy Study to Compare Uniplas With Cryosupernatant Plasma in Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Octapharma 8
Load More Results